7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30 2016-06-30 2015-06-30 2006-03-31 2005-12-31 2005-09-30 
      
    		              
      ​
    		              
      operating activities
    		              
      net income
    		17,224,000 752,000 11,498,000 7,487,000 17,121,000 5,642,000 8,802,000 22,119,000 15,378,000 15,220,000 4,969,000    
      adjustments to reconcile net income to
    		              
      net cash from operating activities:
    		              
      depreciation and amortization
    		12,411,000 9,201,000 8,574,000 8,405,000 7,843,000 8,164,000 7,157,000 6,917,000 6,397,000 6,774,000 5,654,000    
      amortization of debt issuance costs
    		572,000 260,000 213,000 148,000 171,000          
      deferred income taxes
    		8,362,000 -5,236,000 -3,073,000 -686,000 -2,201,000 9,404,000 -1,847,000 -1,624,000 -4,096,000 -20,450,000 6,865,000    
      foreign currency gains
    		  -5,374,000            
      acquisition-related items
    		2,337,000 -512,000  238,000           
      stock-based compensation expense
    		              
      other
    		-476,000 -5,963,000 1,535,000 35,000 1,455,000 198,000 502,000 794,000 219,000 68,000 101,000    
      changes in operating assets and liabilities, net of business acquisition
    		              
      accounts receivable
    		-25,957,000 -11,723,000 -9,650,000 -12,810,000 -9,799,000 24,704,000 -5,755,000 -12,196,000 -12,785,000 -6,530,000 5,002,000    
      inventories
    		-6,161,000 8,532,000 19,236,000 -16,451,000 -4,407,000 -19,514,000 -7,511,000 -2,563,000 1,561,000 3,383,000 -12,621,000    
      other current assets
    		-8,634,000 7,603,000 62,000 75,000 -5,377,000 -9,296,000 -3,062,000 1,901,000 -413,000      
      other assets
    		-2,237,000 3,298,000 1,067,000 643,000 -879,000 -752,000 -152,000 -225,000 -1,048,000 -4,777,000 -4,341,000    
      accounts payable
    		2,619,000 3,901,000 -3,112,000 6,397,000 3,927,000 -3,513,000 7,717,000 -4,338,000 3,269,000 8,470,000 5,995,000    
      accrued expenses and other liabilities
    		26,116,000 9,284,000 -738,000 -591,000 -2,359,000 -5,816,000 9,852,000 -1,907,000 2,803,000 1,658,000 2,000,000    
      net cash from operating activities
    		21,272,000   1,574,000 3,070,000          
      investing activities
    		              
      purchases of short-term investments
    		-4,000,000 0 0 -10,000,000 -24,000,000 -25,000,000 -6,000,000 -37,000,000       
      maturities of short-term investments
    		5,000,000 4,523,000 0 15,100,000 25,000,000 25,000,000 31,000,000        
      capital expenditures
    		-13,142,000 -13,072,000 -10,891,000 -11,890,000 -7,094,000 -10,076,000 -10,117,000 -5,529,000 -5,503,000 -7,704,000 -6,955,000 -6,628,000 -2,217,000 -2,399,000 
      free cash flows
    		8,130,000   -10,316,000 -4,024,000          
      net cash used by investing activities
    		-7,034,000 -9,111,000 -10,282,000 -9,540,000 -7,190,000          
      financing activities
    		              
      revolving credit facility borrowings
    		53,000,000 121,000,000 35,000,000 82,000,000 182,500,000 49,000,000 56,000,000 59,130,000 112,000,000      
      revolving credit facility repayments
    		-58,000,000 -110,000,000 -87,000,000 -61,000,000 -263,500,000 -26,000,000 -56,000,000 -54,630,000 -77,000,000      
      proceeds from long-term debt
    		0  50,000,000           55,000 
      payments of long-term debt
    		-4,061,000 -6,980,000 -3,855,000           -717,000 
      debt issuance costs
    		0  -833,000            
      payments of insurance premium financing and other short-term debt
    		 -3,271,000             
      dividends paid
    		-4,864,000 -4,861,000 -4,861,000 -4,861,000 -4,861,000 -4,855,000 -4,854,000 -4,036,000 -3,986,000 -3,941,000 -3,903,000    
      net cash provided (used) by financing activities
    		-7,766,000   12,389,000 4,637,000 14,985,000  -711,000 -1,975,000 -17,620,000 -917,000    
      effect of exchange rate changes on cash
    		1,213,000 -717,000 419,000 -923,000 592,000 266,000 74,000 -762,000 -53,000 147,000 -174,000 90,000 -21,000 31,000 
      net increase in cash and cash equivalents
    		7,685,000 20,388,000 4,043,000 3,500,000 1,109,000 9,595,000 21,697,000 -1,385,000 6,773,000 1,380,000 8,412,000    
      cash and cash equivalents at beginning of period
    		0 0 0 0 0 0 0 0 0 0 0 0 0 13,001,000 
      cash and cash equivalents at end of period
    		7,685,000 20,388,000 4,043,000 3,500,000 1,109,000 9,595,000 21,697,000 -1,385,000 6,773,000 1,380,000 8,412,000 -1,346,000 944,000 10,154,000 
      foreign currency losses (gains)
    		              
      non-cash impairment charges
    		0              
      pension settlement cost
    		 0       0      
      brazil employment taxes
    		 0             
      stock-based compensation
    		 179,000   0 565,000 565,000        
      changes in operating assets and liabilities, net of business acquisition:
    		              
      business acquisition, net of cash acquired
    		5,349,000 0             
      proceeds from insurance premium financing and other short-term debt
    		 5,899,000             
      supplemental cash flow information
    		              
      interest paid
    		           265,000 10,923,000 364,000 
      income taxes paid
    		           623,000 1,055,000 1,136,000 
      non-cash investing and financing activities
    		              
      property, plant and equipment
    		              
      foreign currency losses
    		              
      proceeds from insurance premium financing
    		              
      payments of insurance premium financing
    		              
      changes in operating assets and liabilities
    		              
      net decrease in cash and cash equivalents
    		              
      foreign currency (gains) losses
    		     -3,216,000 -1,609,000 652,000 -69,000 -2,090,000 1,211,000    
      net cash (used) provided by financing activities
    		 1,787,000             
      gain on sale of investment
    		              
      sale of investment
    		   0           
      payment of contingent consideration
    		   0           
      net cash provided (used) by operating activities:
    		              
      net cash provided (used) by operating activities
    		       10,109,000 13,575,000 26,592,000 21,862,000    
      acquisition-related cost of goods sold
    		       0  965,000     
      changes in operating assets and liabilities:
    		              
      net cash from financing activities
    		              
      business acquisition
    		       0  -30,000     
      net cash (used) provided by operating activities:
    		              
      net cash (used) provided by operating activities
    		              
      cash proceeds from the sale of investment
    		              
      net cash from investing activities
    		              
      (gain) on sale of investment
    		   0           
      foreign currency (gains)
    		   8,684,000           
      changes in operating assets and liabilities, net of business acquisitions:
    		              
      business acquisitions
    		     0 0        
      payments of long-term debt and other
    		   -3,750,000 -206,562,000 -3,160,000         
      property, plant and equipment and capital lease additions
    		              
      net cash used by financing activities
    		              
      issuance of acquisition note payable
    		      0        
      payment of acquisition note payable
    		      0        
      proceeds from common shares issued
    		      0 407,000 2,961,000 52,000     
      net cash (used) by investing activities
    		              
      adjustments to reconcile net income to net cash provided (used) by operating activities:
    		              
      proceeds from common stock issued
    		              
      amortization of debt issuance costs and debt discount
    		      220,000 221,000 254,000      
      acquisition-related costs of goods sold
    		              
      acquisition-related accrued interest
    		       290,000 59,000 393,000     
      net cash provided (used) by investing activities
    		       -10,021,000 -4,774,000 -7,739,000 -12,359,000    
      loss on extinguishment of debt
    		              
      payments of long-term debt, capital leases and other
    		      -3,145,000 -1,582,000 -282,025,000 -731,000 -732,000    
      acquisition-related accrued compensation
    		       68,000 420,000 420,000     
      acquisition-related other
    		              
      amortization of deferred financing costs and debt discount
    		         255,000 242,000    
      payment of premiums and costs on extinguished debt
    		              
      accrued interest
    		          20,000    
      deferred income taxes valuation allowance
    		              
      prepaid expenses and other current assets
    		          5,967,000    
      borrowings under the revolving credit facility
    		              
      repayments of the revolving credit facility
    		              
      acquisition related accrued compensation
    		          420,000    
      acquisition related accrued interest
    		          378,000    
      borrowings under the revolving and domestic senior credit facility
    		              
      repayments of the revolving and domestic senior credit facility
    		              
      capital / leasehold improvements and capital lease additions
    		              
      borrowings under the domestic senior and revolving credit facility
    		              
      repayments of the domestic senior and revolving credit facility
    		              
      proceeds from new common shares issued
    		              
      capital/leasehold improvements
    		              
      capital lease additions
    		           5,000   
      net
    		           -1,359,000 -2,015,000 -2,791,000 
      adjustment for discontinued operations
    		              
      (loss) from continuing operations
    		           -1,359,000 -2,015,000 -2,791,000 
      adjustments to reconcile (loss) from continuing operations to net cash provided (used) by operating activities:
    		              
      cash provided (used) by discontinued operations
    		              
      proceeds from belgium plant transactions
    		           0   
      proceeds from sales of assets
    		           1,697,000 -501,000 738,000 
      other investing
    		              
      discontinued operations
    		              
      net increase in book overdrafts
    		              
      payments of long-term debt and capital leases
    		           -785,000   
      proceeds from capital contribution by pahc holdings corporation
    		              
      redemption of series c preferred stock
    		              
      debt financing costs
    		              
      operating activities:
    		              
      amortization of deferred financing costs
    		              
      net gain from sales of assets
    		              
      effects of changes in foreign currency
    		              
      accrued costs of non-completed transaction
    		              
      accrued costs of the belgium plant transactions
    		              
      investing activities:
    		              
      financing activities:
    		              
      net increase in cash overdraft
    		            1,410,000 223,000 
      net (decrease) in short-term debt
    		              
      supplemental cash flow information:
    		              
      adjustments to reconcile (loss) from continuing operations to net cash from operating activities:
    		              
      net increase in short-term debt
    		             -3,713,000 
      income from continuing operations
    		              
      adjustments to reconcile income from continuing operations to net cash provided (used) by operating activities:
    		              
      payment of pfizer obligations
    		              
      payments relating to the prince transactions and related costs
    		              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.